Educational Platforms & Resources

Alchemy — stakeholder linked to psychedelic research. Details pending verification.

US-based philosopher, researcher, and psychedelic integration guide with a Master's degree in philosophy focused on the nature of healing in the psychedelic experience, who has worked as a research assistant at a ketamine clinic and written curriculum for multiple psychedelic therapy certificate programs. Criddle offers a Philosophy and Psychedelics online course and integration coaching, has contributed to Blossom Analysis and Psychedelic Science Review, and co-produced the documentary EntheoMagus exploring the psychedelic origins of Mormonism and the role of entheogens in American occultism.

Psychedelic science education platform founded by British neurobiologist and pharmacologist Andrew R. Gallimore in Tokyo, focused on the neuroscience of DMT, consciousness, and psychedelic pharmacology. Gallimore co-authored a landmark 2016 paper with Rick Strassman proposing target-controlled intravenous DMT infusion for sustained immersive experiences, and publishes the Alien Insect On Drugs Substack alongside immersive educational workshops.

Altered States Integration is an online organization offering psychedelic integration, education, and harm- and risk-reduction services, including 1:1 coaching, group integration circles, workshops, and leadership training. They provide resources and events to help individuals and communities prepare for and integrate altered-state/psychedelic experiences.

ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.

Founded in 2020, the Autistic Psychedelic Community (APC) is a Los Angeles-based peer support and co-learning network focused on the intersection of psychedelics and neurodivergent conditions including autism and ADHD, offering psychedelic integration support, panel discussions with researchers, and academic partnerships. Cited in peer-reviewed research, the APC promotes neurodiversity-affirming approaches to psychedelic practice and safe access.

AYA Healing Retreats is an ayahuasca retreat center located outside Iquitos, Peru, offering authentic traditional healing ceremonies led by curandero families with multigenerational experience in Amazonian plant medicine. Their small-group retreats include individualized preparation, one-on-one consultations with healers, vapor baths, icaros, and post-retreat integration sessions.

Fundación Beckley Med is a Barcelona-based psychedelic research and education organisation, partnered with the UK's Beckley Foundation, that funds and disseminates psychedelic-assisted therapy studies and provides professional training through institutional affiliations with MAPS, Grof Legacy, and CIIS. It collaborated with CITA Clinic to deliver experimental ketamine treatment to patients with treatment-resistant depression in Spain.

Being True to You (BTTY) is a pioneering Denver-based psychedelic integration and addiction recovery coaching company founded in 2010 by Deanne Adamson, operating the first and most comprehensive Transformational & Integration Coach Training Program with over 500 certified coaches worldwide. The organization offers one-on-one integration coaching, 12-month coach certification, and sitter and retreat staff training, partnering with wellness retreats, ibogaine programs, and psychedelic providers globally.

UC Berkeley Center for the Science of Psychedelics (BCSP), founded in September 2020 by a multidisciplinary faculty group including neuroscientist Michael Silver and author Michael Pollan, conducting psilocybin research into cognition, perception, emotion, and their neural bases in the human brain. BCSP's four pillars of basic science, journalism, culture, and community have established it as a leading interdisciplinary hub for psychedelic research and public engagement, producing The Microdose newsletter and a global clinical trials map.

Bonfire — stakeholder linked to psychedelic research. Details pending verification.

Breakthrough Therapies is a Toronto-based ketamine-assisted psychotherapy clinic and training organization founded by Dr. Dawn DeCunha, offering certified KAP training programs (Level 1 and Level 2 mentoring practicum) alongside a clinical KAP retreat program at their Aspenwood location north of Toronto. The organization bridges Trauma Informed and Psychedelically Informed Practice, training clinicians in psychedelic psychotherapy principles while providing patient care.

COMPASS Pathways is a UK-listed biopharmaceutical company developing COMP360 synthetic psilocybin therapy for treatment-resistant depression, with two successful Phase 3 trials making it the leading candidate for the first regulatory approval of a classic psychedelic medicine.

Ibogaine preparation, integration, and aftercare coaching platform founded in 2009 by Jonathan Dickinson, former Director of the Global Ibogaine Therapy Alliance. Ceiba provides personalized one-on-one coaching across all phases of the ibogaine experience, grounded in harm reduction, neurodiversity, and spiritual emergence perspectives, and offers a free weekly recovery group for ibogaine treatment alumni.

US-based nonprofit institute founded by Brazilian anthropologist Dr. Bia Labate that bridges psychedelic plant medicine traditions and emerging clinical science, producing research and accessible cultural commentary on ayahuasca, psilocybin, and other plant medicines while centering Indigenous reciprocity, racial equity, and social justice. Chacruna hosts annual interdisciplinary conferences since 2018, operates a Racial Equity and Access Committee, and amplifies voices of Indigenous peoples, women, queer communities, and the Global South in psychedelic science and policy.

UK-based specialist CNS and psychiatry-focused clinical research organization combining select CRO services, dedicated trial sites, participant recruitment, and psychedelic therapist training for complex mental-health studies.

Clinical Cognitive Facilitator Training (Clinical Cognitive Training) is a Portland, Oregon–based training center that provides state-approved psilocybin facilitator training via a hybrid didactic and experiential practicum model. The program is clinically focused, culturally respectful, and prepares students to meet Oregon's facilitator licensing requirements.

Cybin Inc. (founded 2019) is a Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapeutics—now operating as Helus Pharma—focused on proprietary novel serotonergic agonists and deuterated psilocin analogs for mental health conditions.

DOSED is an independent documentary film project producing award-winning films about psychedelic-assisted therapy, produced by Golden Teacher Films. Its debut film (2019) follows Adrianne, a woman who overcomes opioid addiction, anxiety, and depression using underground psilocybin mushrooms and ibogaine therapy. The sequel, Dosed: The Trip of a Lifetime (2022), follows Laurie, a cancer patient who turns to plant medicines including psilocybin and cannabis alongside her diagnosis. The project includes a streaming platform and educational resources.

Door of Perception is the practice of Dorien, a Netherlands-based psychedelic guide, coach, and medical anthropologist who co-founded the OPEN Foundation in 2007 and brings over 20 years of experience in harm reduction at festivals such as Kosmicare, Zendo, and Psycare. She offers online courses for safe DIY psychedelic journeys, one-on-one psilocybin truffle sessions in Amsterdam, and training workshops for guides and mental health professionals.

Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.

Oregon-based program offering psilocybin facilitator training that blends Indigenous plant-medicine knowledge, ecological perspectives, and contemporary therapeutic practices to prepare licensed facilitators. It focused on cohort-based education, practicum hours, and inclusion of marginalized communities.

The University of Exeter is a public research university based in Exeter, Devon, England, with additional campuses in Cornwall. It provides undergraduate and postgraduate education and conducts research across a wide range of disciplines.

Miami public research university where Dr. Jerry B. Brown has taught interdisciplinary psychedelics courses since 1975, and Professor Joseph Lichter runs an Honors College Psychedelic Renaissance course covering therapeutic applications of psilocybin, MDMA, and ketamine. FIU also serves as one of 21 sites in a major national psychedelic clinical trial and hosts the Cannadelic conference — the first cannabis and psychedelics conference focused on next-generation research.

Vrije Universiteit Amsterdam (VU Amsterdam) is a major Dutch research university where neuroscientist Marco Aqil conducted the first psilocybin brain research in Amsterdam, demonstrating that psilocybin fundamentally alters visual processing by reducing cortical surround suppression. The university also hosts the Amsterdam Psychedelic Research Association (APRA) and offers an interdisciplinary honors course on the neuroscience, history, and therapeutic potential of psychedelics.

One of Europe's foremost centres for psychedelic-assisted therapy, operating within Switzerland's compassionate use framework. Under Professor Daniele Zullino, HUG treats depression and PTSD with psilocybin, LSD, and MDMA, and hosts one of five university-affiliated psychedelic research laboratories in Switzerland.

Guides Collective is a private community and concierge matching service connecting individuals seeking psychedelic-assisted healing with a vetted network of 600+ practitioners across the US and Canada. All guides undergo in-depth screening, background checks, and must have at least two years of professional experience. The organization also provides business education, marketing support, mentorship programs, and peer community resources to help guides build sustainable practices.

Harvard University hosts multiple psychedelic research initiatives including the Study of Psychedelics in Society and Culture (a $16M program), the MGH Center for the Neuroscience of Psychedelics, and the Harvard Law School POPLAR project addressing psychedelic policy reform. These programs span neuroscience, cultural studies, and legal advocacy to advance scientific and societal understanding of psychedelics.

Non-profit founded in 2009 and headquartered in Barcelona, dedicated to transforming society's relationship with psychoactive plants including ayahuasca, iboga, and cannabis. ICEERS combines scientific research, legal advocacy, harm reduction services, and ethnobotanical education — including conducting the world's first ibogaine clinical trial for opioid dependency.

Innate Path is a Broomfield, Colorado psychedelic therapy clinic and training program specializing in ketamine and cannabis-assisted psychotherapy using a relational, somatic, and Buddhist-informed approach to trauma resolution through non-ordinary states. The center trains psychotherapists in its unique psycholytic model — integrating somatic, psychodynamic, parts work, and attachment modalities — while providing clinical ketamine and cannabis-assisted psychotherapy to patients.

A Brazil-based hub for education, clinical care, research and innovation focused on psychedelic-assisted therapies and mental health; offers clinical services, postgraduate training and conducts research protocols (including psilocybin studies).

The Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.

The Ketamine Research Institute is a US-based clinical research organization developing precision medicine approaches to ketamine infusion therapy, studying optimized dosing protocols to treat depression and offering clinician training in evidence-based ketamine practice.

Founded in 2006 by Eli Jaxon-Bear, the Leela School of Awakening is an Ashland, Oregon-based 501(c)(3) nonprofit offering an Oregon HECC-approved 10-month psilocybin facilitator training program alongside 2-year therapist certification and international spiritual awakening retreats. Their approach integrates trauma-informed care, clinical hypnosis, Enneagram, and self-inquiry tools with psilocybin facilitation.

Nonprofit organizer and host of the Psychedelic Science conference series, alongside broader educational and policy programming.

European nonprofit research and implementation organization that organizes the INSIGHT Conference and allied public/professional events.

While Maastricht University may not have a single dedicated psychedelic research group, various researchers at the university are investigating the effects of psychedelics. Early research exploring psychedelics at Maastricht focused on the dangers of MDMA. Now, research into the effects of microdosing is being led by Dr Kim Kuypers. Other research ongoing at the university is investigating cannabis as well as novel psychoactive substances (NPS). Maastricht is collaborating on research with the Beckley Foundation as well as Silo Pharma.

Maps of the Mind is a psychedelic education and facilitation organisation that offers workshops, coaching, private sessions and retreats to increase access to safe and beneficial psychedelic experiences. The site also publishes educational content on mindfulness, preparation and integration for psychedelic journeys.

Industry media and events platform that organizes psychedelic-focused conference programming and business-community convenings.

Founded in 2011, Mindspace Wellbeing is a Montreal-based psychology clinic that pioneered psychedelic-assisted therapy in Quebec, becoming the province's first provider of ketamine-assisted psychotherapy for treatment-resistant depression and launching Canada's first psychedelic harm reduction and integration training for clinicians. Acquired by Numinus Wellness in 2021, they continue offering evidence-based psychotherapy alongside ketamine and psilocybin programming.

Public university in St. Joseph, Missouri, home to Dr. Christine Ziemer's pioneering undergraduate courses in psychedelic-assisted psychotherapy and transpersonal psychology covering psilocybin, LSD, MDMA, ketamine, and ayahuasca research and therapeutic applications. Dr. Ziemer founded the Psychedelic Educators Network, serves as executive director of the Psychedelic Society of Kansas City, and supports harm reduction through the Fireside Project and Zendo Project, making Missouri Western a notable hub for Midwestern psychedelic education.

Modern Spirit is a U.S.-based 501(c)(3) nonprofit that promotes and researches spiritual healing in modern healthcare through scientific projects, educational programs, retreats, and community initiatives (including work on psychedelic-assisted therapies).

The Clinical Psychedelic Lab, led by Dr. Paul Liknaitzky, conducts robust clinical trials exploring the efficacy and safety of psychedelic-assisted therapies for various mental health conditions within the Australian healthcare context.

The Center for Psychedelic Medicine at NYU Langone Health is directed by Dr. Michael Bogenschutz and performs health-focused research across the translational spectrum, from basic science to large-phase clinical trials. The center has three transdisciplinary areas of focus: psychiatry, medicine, and preclinical research. Currently, the team is actively investigating clinical applications for various psychedelic compounds, leading robust studies on psilocybin-assisted therapy for alcohol use disorder, major depression, and advanced cancer-related psychiatric distress.

Numinus Wellness Inc. is a Vancouver-based mental health company focused on psychedelic-assisted therapy: it provides practitioner training, clinical research services, and (formerly) operated clinics and a Health Canada‑licensed bioscience laboratory for psychedelic research and product development.

Dutch nonprofit organizer in the psychedelic field, including stewardship of the ICPR conference series and related professional convenings.

The Ohio State University is a public land-grant research university based in Columbus, Ohio, offering undergraduate, graduate, and professional programs and conducting research across many fields. It was founded as the Ohio Agricultural and Mechanical College and serves as a major educational and economic institution in Ohio.

Portland Psychotherapy is a Portland, Oregon clinic, research, and training center that integrates psychedelic science into evidence-based clinical practice, conducting clinical trials of MDMA-assisted therapy for social anxiety disorder and offering psychedelic integration services. Their distinctive model funds peer-reviewed research through clinical revenue, resulting in exceptionally well-trained therapists in psychedelic-assisted care.

PsiloHealth is a psilocybin education, harm reduction, and advocacy organization founded by licensed pharmacist and educator Dr. Sa'ed Al-Olimat, offering a Psilocybin Peer Supporter (PPS) certification, integration workshops, and free educational resources on psilocybin's therapeutic applications. The organization advocates for equitable access to psilocybin-supported care through community education and legislative engagement.

The Psychedelic Medicine Association (PMA) is a professional association that educates and connects healthcare practitioners about the therapeutic use of psychedelic medicines. It also develops clinical practice guidelines, training accreditation, and related infrastructure to support safe integration of psychedelic therapies into mainstream healthcare.

Psychedelic Support is an online education and therapeutic platform offering accredited continuing education, online courses, and a vetted directory of licensed healthcare providers and community groups focused on psychedelic integration, harm reduction, and clinical referrals. It was founded in March 2018 to advance legal psychedelic-assisted therapies and professional training. ([psychedelic.support](https://psychedelic.support/our-story/))

Digital-first psychedelic media platform publishing podcasts, video content, newsletters, and online storytelling for professional and public audiences.

Canadian nonprofit research and education organization advancing a systems-based and ecological approach to psychedelics in service of planetary health, developed through interdisciplinary research at the University of Ottawa. Psygaia's framework positions psychedelics as ecological mediators that reweave the human relationship with the living Earth, offering the Microdosing Mindfully course, the Psygaia Circle integration community, guided journey support, and the AFTERGLOW seasonal integration event series across North America.

Salt City Psychedelic Therapy and Research (SCPTR) is a Utah-based nonprofit founded by the late Dr. Parth Gandhi to advance psychedelic-assisted therapy through education, research, and advocacy in the Intermountain West. SCPTR organizes the annual Intermountain Psychedelic Symposium and supports practitioners, researchers, and policy reform in the region.

SoundMind Institute is a Philadelphia-based psychedelic-assisted psychotherapy training, treatment, and research organization founded by Dr. Hannah McLane, offering a comprehensive year-long Psychedelic Practitioner Training Program and ketamine-assisted psychotherapy treatment. Integrating Indigenous healing traditions with clinical evidence, its nonprofit arm has provided over $280,000 in scholarships to BIPOC and underrepresented psychedelic providers.

At the Stanford School of Medicine, researchers from the Rodriguez Lab and the Heifets Lab have united under the banner of the Stanford Psychedelic Science Group. Their primary clinical focus is to investigate compounds including ketamine, psilocybin, and MDMA as potential treatments for debilitating disorders such as obsessive-compulsive disorder (OCD), treatment-resistant depression, and post-traumatic stress disorder (PTSD).

Subtle Winds is a facilitator training and transformative healing center based in Eugene, Oregon that offers psilocybin facilitator training, workshops, and community programs to prepare students for Oregon Health Authority certification. The organization emphasizes equitable access and training for historically marginalized communities.

Tam Integration offers psychedelic integration support through Mt. Tamalpais Integration Circles in the San Francisco Bay Area and a year-long integration coach training program for practitioners. The organization also hosts the annual Mt. Tam Integration Jam conference, fostering community among Bay Area integration practitioners.

Founded in 2019 by Dr. Rafael Gonzalez-Vizoso and Scott Ross, Telos is a Mountlake Terrace, Washington practice offering ketamine-assisted psychotherapy through a collaborative model that enables licensed practitioners to integrate psychedelic-assisted therapy into their practices. They also offer training in core competencies of ketamine-assisted therapy for mental health providers.

An online educational program and resource offering interviews, manuals, and training materials from experienced psychedelic practitioners about holding space and best practices for psychedelic-assisted sessions. It provides audio/video presentations and a manual (edited by James Fadiman) as a free master class on psychedelic care.

TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.

Digital platform combining psychedelic education, media publishing, and multimedia content formats for consumer and practitioner audiences.

Psilocybin community and harm reduction education hub with a mission to create a world where everyone has safe access to psychedelic medicines. Tripsitters.org covers harm reduction, pharmacology, therapy, ethics, and integration, maintaining a comprehensive directory of psychedelic organizations and practitioners; it is featured as a key resource by the UC Berkeley Center for the Science of Psychedelics.

The University of Groningen's medical center (UMCG) is a leading European hub for psychedelic research, coordinating the EU-funded €6.5M PsyPal clinical trial studying psilocybin for psychological distress in palliative care patients. UMCG also hosts an annual interdisciplinary summer school in psychedelic research in collaboration with the OPEN Foundation and partner universities.

The University of Amsterdam (UvA) is one of the Netherlands' leading research universities, with its Amsterdam UMC Department of Psychiatry conducting clinical trials on psilocybin and psychedelic-assisted therapies for treatment-resistant mental health conditions.

The Penn Psychedelics Collaborative at the University of Pennsylvania is a multi-school consortium of researchers, clinicians, and faculty advancing transdisciplinary psychedelic science across Penn Medicine and Penn Nursing, including clinical trials of MDMA-assisted therapy and psilocybin research. Penn researchers are also leading the development of bioethical guidelines for psychedelic-assisted therapy and community implementation frameworks.

The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances is dedicated to exploring the scientific, historical, and cultural aspects of psychoactive substances, focusing on psychedelics.

The U.S. Department of Labor’s Veterans' Employment and Training Service (VETS) is a federal agency that prepares veterans, service members, and military spouses for civilian employment, enforces veterans’ employment rights, and administers related programs and grants. It provides resources, training, and oversight of programs such as the HIRE Vets Medallion, Jobs for Veterans State Grants, and transition assistance.

In response to the fallout from the COVID-19 pandemic, a research group at Vancouver Island University (VIU) has been awarded funding from the Canadian Institutes of Health Research for the exploration of psychedelic therapies for front-line workers. Led by Dr Shannon Dames, the team are currently focusing on ketamine-assisted therapy for front-line workers experiencing symptoms of PTSD and emotional distress as a result of their experiences working through the pandemic.